Login / Signup

Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study.

Nicolas WillietAngelica PetrilloGaël S RothMichele GhidiniMila PetrovaJulien ForestierAnthony LopezAudrey ThoorLucie WeislingerFerdinando De VitaGilles ManceauJean Marc Phelip
Published in: Cancers (2021)
This retrospective study did not show any difference between GN and FFX as the first-line treatment in patients with LAPC.
Keyphrases
  • locally advanced
  • rectal cancer
  • neoadjuvant chemotherapy
  • squamous cell carcinoma
  • radiation therapy
  • phase ii study
  • advanced non small cell lung cancer
  • clinical trial
  • lymph node
  • open label